Recurrent arthritis as an unexpected side effect associated with azacitidine in a patient with myelodysplastic syndrome

ILTAR U., ALHAN F. N., VURAL E., ATAŞ Ü., SÖZEL H., DOĞAN Ö., ...Daha Fazla

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, cilt.28, sa.2, ss.500-503, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1177/10781552211049728
  • Dergi Adı: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Sayfa Sayıları: ss.500-503
  • Anahtar Kelimeler: azacitidine, demethylating agent, myelodysplastic syndrome, arthritis, crystal-induced arthritis, AGENTS
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Introduction Hypomethylating agents have confirmed efficacy for myelodysplastic syndrome and acute myeloid leukemia and are widely used. Although arthralgia is common side effect associated with hypomethylating agents, arthritis has not been reported previously.